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Abstract Little is known about the physiological role and
mechanism of activation of class II phosphoinositide 3-kinases
(PI3Ks), although it has been shown that the PI3K-C2K isoform
is activated by insulin. Using chimaeric receptor constructs which
can be activated independently of endogenous receptors in
transfected cells, we found that PI3K-C2K activity was
stimulated to a greater extent by insulin receptors than IGF
receptors in 3T3-L1 adipocytes. Activation of PI3K-C2K
required an intact NPEY motif in the receptor juxtamembrane
domain. We conclude that PI3K-C2K is a candidate for
participation in insulin-specific intracellular signalling.
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1. Introduction
A great deal of evidence has accumulated to indicate that
phosphoinositide 3-kinase (PI3K) activity is a necessary com-
ponent in the signalling pathways emanating from receptor
tyrosine kinases [1]. There are four distinct classes of enzymes
with PI3K activity, two of which are known to be activated by
receptor tyrosine kinases [2]. The three isoforms of the cata-
lytic subunits of class-Ia PI3K associate with adapter subunits
containing two SH2 domains and are activated when these
interact with phosphotyrosines in speci¢c sequence motifs.
Three class-II PI3K isoforms have been identi¢ed, which
lack adapter subunits and SH2 domains but are characterised
by the presence of a C-terminal C2 domain. We have recently
shown that the K isoform of class-II PI3K (PI3K-C2K) can be
activated by insulin in cells with high numbers of insulin re-
ceptors [3]. However, even high concentrations of insulin pro-
duced little stimulation of PI3K-C2K in 3T3-L1 ¢broblasts.
This is somewhat surprising as these cells have signi¢cant
numbers of IGF-I receptors which should be activated by
high concentrations of insulin. In general insulin and IGF-I
induce very similar metabolic responses in cells [4], although
we have recently demonstrated that their receptors activate
certain pathways to di¡erent extents [5]. Therefore our ¢nding
that PI3K-C2K is not activated by high doses of insulin in
3T3-L1 ¢broblast suggests that the insulin receptor (IR) may
be more e¡ective than the type I IGF-I receptor (IGFR) in
activating this form of PI3K.
The mechanism by which insulin activates class-II PI3Ks is
not known. PI3K-C2K is not itself tyrosine phosphorylated
but it does associate with a 160 kDa protein that becomes
tyrosine phosphorylated after insulin stimulation in HEK293
cells [3]. One clue to the mechanism of activation may be
provided by a sequence homology identi¢ed between the car-
boxy-terminal region of PI3K-C2K and the phosphotyrosine
binding (PTB) domain of IRS 1 (M.D. Water¢eld, personal
communication) suggesting direct association with receptors
might be involved in class-II PI3K activation. The tyrosine
960 on the IR and the corresponding tyrosine 950 on the
IGFR, within NPEY sequence motifs, have been identi¢ed
as binding sites for the PTB domains in SHC and IRS-1 [6^9].
We have recently developed chimaeric receptors, in which
the extracellular portion of the TrkC receptor is linked to the
intracellular portion of either the IR or IGFR, as tools to
study mechanism and speci¢city in insulin/IGF-I signalling
[5,10]. Addition of the TrkC ligand (NT-3) allows speci¢c
activation of either the IR or IGFR chimaeras without acti-
vation of endogenous receptors in transfected cells. Using this
system we obtained evidence that insulin and IGF-I may ac-
tivate distinct pools of class-Ia PI3K [5]. In the present study,
we have used the chimaeric receptor system for a direct com-
parison of the e⁄cacy of insulin and IGF-I receptors in acti-
vating class-II PI3K. We have also modi¢ed these chimaeric
constructs by mutating tyrosine to phenylalanine at position
960 in the IR and 950 in the IGFR to determine whether these
residues are required for stimulation of class-II PI3K.
2. Materials and methods
2.1. Chimaeras and cell lines
Chimaeras containing the extracellular and transmembrane por-
tions of the neurotrophin receptor TrkC together with the intracellu-
lar portion of the human IR or IGFR (TIR and TIGR respectively)
were constructed as previously described [10]. Point mutations (TIR
Tyr960CPhe, TIR960; TIGR Tyr950CPhe, TIGR950) were created
by Quick Change site directed mutagenesis kit (Promega), and the
sequence veri¢ed using a Sequenase version 2.0 DNA sequencing kit
(Amersham). The chimaeras were expressed under the regulation of
the EF-1K promoter (a kind gift from Dr R.E. Lewis, Eppley Institute
for Research in Cancer, University of Nebraska) in the vector
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pcDNA3 (Invitrogen). 3T3-L1 ¢broblasts (from ATCC) were main-
tained at no higher than 80% con£uence in DMEM containing 10%
NCS, 4.5 g/l glucose, 2 mM glutamine and antibiotics (DMEM/NCS)
and for di¡erentiation they were grown as previously described [5].
Di¡erentiated cells were used after 10^12 days and only when at least
90% of the cells showed adipocyte phenotype by accumulation of lipid
droplets. Clones of 3T3-L1 ¢broblasts expressing TIR and TIGR were
as previously described and clones expressing the TIR960 and
TIGR950 mutants were isolated at the same time.
2.2. Antibodies
Rabbit antibodies directed against the carboxy-terminal domains of
the IR or IGFR were as previously described [5]. Rabbit antibody to
PI3K-C2K was also as described [3]. Mouse monoclonal anti-phos-
photyrosine antibody 4G10 was from NEB. HRP-linked secondary
antibodies were from Dako and 125I-labelled secondary antibodies
were prepared by in-house iodination of antibodies from Sigma.
2.3. Receptor autophosphorylation
Serum starved adipocytes were stimulated for 5 min and solubilised
in lysis bu¡er (50 mM HEPES, 150 mM NaCl, 1 mM EDTA, 30 mM
NaF, 1% Triton X-100, 1 mM Na3VO4, 10 mM Na2P2O7, 0.1 mM
AEBSF, 2.5 mM benzamidine, 1 Wg/ml antipain, 1 Wg/ml leupeptin,
1 Wg/ml pepstatin A) and the lysate clari¢ed by centrifugation at
13 500Ug for 15 min at 4‡C. Crude lysates were resolved by SDS-
PAGE before electroblotting to PVDF membranes (Millipore), and
receptor autophosphorylation levels detected by incubation with anti-
phosphotyrosine antibody in TBST bu¡er (150 mM NaCl, 50 mM
Tris, 0.1% Tween 20), after blocking in 1% BSA, followed by 125I-
labelled secondary antibodies (approximately 0.2 WCi per blot) and
quanti¢ed on a Fujix BAS2000 Phosphorimager.
2.4. Analysis of association between receptors and PI3K-C2K
Lysates prepared as described for receptor autophosphorylation
were subjected to immunoprecipitation using either anti-IR (1:100),
anti-IGFR (1:100) or anti-PI3K-C2K (1:100) antibodies plus protein
A-agarose (2 mg/sample). Immunoprecipitates were washed once in
lysis bu¡er and twice in PBS in the cold, resolved by SDS-PAGE, and
Western blotted onto PVDF membranes which were then probed with
anti-PI3K-C2K or anti-phosphotyrosine antibodies as previously de-
scribed [3]. The blots were developed by incubation with HRP-linked
secondary antibodies and detection by enhanced chemiluminescence
(ECL) and exposure against Hyper¢lm MP autoradiography ¢lm
(Amersham International).
2.5. PI3K-C2K activity
Cells were stimulated for 5 min, lysed and immunoprecipitated with
anti-PI3K-C2K antibody. The immunoprecipitates were washed and
assayed for lipid kinase activity as previously described [3], and the
radiolabelled phosphatidylinositol 3-phosphate produced was quanti-
¢ed on a Fujix BAS2000 Phosphorimager.
3. Results
3.1. Expression of chimaeric receptors
Clones of stably transfected 3T3-L1 ¢broblasts were se-
lected which expressed chimaeric receptors consisting of the
extracellular portion of TrkC fused to TIR, TIGR, or the
same receptors mutated within the juxtamembrane region at
IR Tyr960CPhe (TIR960) or the corresponding IGFR
Tyr950CPhe (TIGR950). Autophosphorylation of these ty-
rosine residues has been shown to be crucial for recruitment
of receptor substrates, and mutation of these sites compro-
mises signalling via IRS- and SHC-dependent pathways and
downstream metabolic responses.
Cells were stimulated to di¡erentiate into adipocytes, and
the levels of chimaeras compared by performing anti-phos-
photyrosine blotting to assess receptor autophosphorylation
in NT-3-stimulated cells. The various clones expressed similar
levels of chimaeras, within a factor of 2 (Fig. 1), and the
Fig. 1. Characterisation of chimaeras. Clonal lines of 3T3-L1 adipo-
cytes as indicated were left unstimulated (0) or stimulated with 4nM
NT-3 (N) or 100 nM insulin (I) for 5 min, lysed and resolved by
SDS-PAGE before Western blotting with anti-phosphotyrosine anti-
body. The region of the blots containing the chimaeric receptors
(approx. 160 kDa) is shown. Numbers indicate average amount of
auto-phosphorylated receptor relative to TIR from three independ-
ent experiments.
Fig. 2. PI3K-C2K activity. Experiments were conducted with clonal
lines of 3T3-L1 adipocytes (A) or ¢broblasts (B). Cells were left un-
stimulated, or stimulated with 0.4 nM NT-3 (white bars) or 4 nM
NT-3 (black bars) or with insulin (A: 100 nM; B: 1 WM) for
5 min, before lysis and determination of lipid kinase activity in anti-
PI3K-C2K immunoprecipitates. Results are presented as fold stimu-
lation over basal and are means þ S.E.M. from 3^5 independent ex-
periments performed in duplicate. Statistically signi¢cant di¡erences
between activities in TIR and TIGR cells are indicated. Fold stimu-
lations with insulin were (A): TIR 1.82 þ 0.12; TIGR 1.69 þ 0.09;
TIR960 1.64 þ 0.15; TIGR950 1.58 þ 0.05; and (B): TIR 1.58 þ 0.40;
TIGR 1.35 þ 0.23; TIR960 1.43 þ 0.31; TIGR950 1.54 þ 0.19.
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results of these blotting experiments were con¢rmed by bind-
ing studies with radio-iodinated NT-3 (data not shown).
3.2. Activation of PI3K-C2K
The capacity of IR and IGFR to mediate stimulation of
class-II PI3K was assessed by measuring lipid kinase activity
in anti-PI3K-C2K immunoprecipitates from chimaera-trans-
fected adipocytes which had been stimulated with NT-3 or
insulin (Fig. 2A). These studies focussed on the C2K isoform
as we were unable to detect the C2L isoform in 3T3-L1 adi-
pocytes [3] and expression of the C2Q isoform is restricted to
liver [11]. In all cells (TIR, TIGR, TIR960, TIGR 950) PI3K
activity in the anti-PI3K-C2K immune complex assay was
stimulated 1.5^1.8-fold by insulin, acting through endogenous
IR. In TIR cells, NT-3 at submaximally and maximally e¡ec-
tive concentrations (0.4 and 4 nM) induced increases in PI3K-
C2K activity which were comparable to or greater than those
with insulin (2.2- and 1.7-fold respectively). However, in
TIGR cells NT-3 was less e¡ective than insulin in stimulating
PI3K-C2K activity (1.3- and 1.4-fold at 0.4 and 4 nM NT-3),
and compared to TIR cells this di¡erence in e¡ectiveness of
NT-3 was statistically signi¢cant.
A very similar pattern of responses was observed when
PI3K-C2K activity was studied in 3T3-L1 ¢broblasts (Fig.
2B). In this case two independently derived pairs of matched
TIR and TIGR clones were available, and in both pairs the
stimulation of PI3K-C2K activity via TIR was greater than
via TIGR. The level of PI3K-C2K activity in ¢broblasts, as
measured in immunoprecipitates and expressed per mg of to-
tal protein, was approximately half of that in adipocytes (data
not shown) and the fold stimulations by insulin and NT-3
were also somewhat lower in ¢broblasts than adipocytes.
No e¡ect of NT-3 on PI3K-C2K activity was observed in
adipocytes expressing chimaeras with juxtamembrane muta-
tions (TIR960 and TIR950) (Fig. 2A). This lack of stimula-
tion suggested either that the juxtamembrane tyrosine residues
might be involved directly in PI3K-C2K recruitment, or indi-
rectly in activation of PI3K-C2K by established IRS-depend-
ent signalling pathways.
3.3. Association between PI3K-C2K and receptors
To test whether the PI3K-C2K associates directly with re-
ceptors, we stimulated chimaera-expressing adipocytes with
NT-3 and analysed anti-receptor immunoprecipitates by
anti-PI3K-C2K immunoblotting. PI3K-C2K was readily de-
tected in anti-PI3K-C2K immunoprecipitates, but not in either
anti-IR or anti-IGFR immunoprecipitates (Fig. 3). Con-
versely, phospho-receptor was readily detected by anti-phos-
photyrosine blotting of anti-receptor immunoprecipitates, but
no phospho-receptor was detected in anti-PI3K-C2K immuno-
precipitates (Fig. 3).
4. Discussion
The use of chimaeric receptors has allowed us to extend our
previous ¢ndings [3] and to demonstrate clearly that the IR is
able to activate PI3K-C2K. This approach further allowed us
to establish that activation of the IR causes a much greater
increase in PI3K-C2K activity than does activation of the
IGFR. Although the cellular roles of class-II PI3Ks are as
yet unclear, this ¢nding highlights yet another di¡erence be-
tween IR and IGFR in their capacity to activate PI3Ks, our
previous work having established that the receptors also di¡er
in their capacity to stimulate class Ia (IRS-1-associated) PI3K
activity [5]. These di¡erences in the extent of PI3K stimulation
are likely to result in divergence in signalling outcome and in
metabolic e¡ects such as the stimulation of glucose transport
[1].
The present data also provide insights into the mechanism
by which insulin regulates class-II PI3K activity. Mutation of
the NPXY motifs on the IR and IGFR completely abrogated
activation of the PI3K-C2K suggesting that association with a
PTB domain-containing protein is required [12]. IRS proteins
are candidates to play such a role, although there is no ob-
vious mechanism by which class II PI3Ks and IRS proteins
could interact directly. Indeed we have previously shown that
PI3K-C2K does not associate with IRS-1 in insulin-stimulated
cells, and that no tyrosine phosphorylated proteins of a size
corresponding to IRS-1 or IRS-2 are observed in anti-PI3K-
C2K immunoprecipitates [3]. Another possibility is that acti-
vation of PI3K-C2K requires signalling pathways initiated by
IRS proteins, perhaps involving class Ia PI3K and down-
stream protein kinase cascades [1]. A ¢nal and intriguing pos-
sibility is the fact that PI3K-C2K itself possesses a putative
PTB domain (M.D. Water¢eld, personal communication)
which might mediate direct association with the receptor.
Although we were unable to detect PI3K-C2K in anti-IR im-
munoprecipitates, this does not rule out the occurrence of
such an interaction within intact cells, as it has also proved
di⁄cult to demonstrate direct association between IRS pro-
teins and the IR even though there is a large amount of in-
direct evidence that interaction of the IRS-1 PTB domain with
the insulin receptor is essential for insulin signalling [13]. It is
notable that the residues £anking NPEY motifs, which are
responsible for ¢ne speci¢city of interactions with PTB do-
mains of IRS and SHC proteins [14,15], are conserved be-
tween the IR and IGFR. Therefore, whatever the nature of
the PTB-receptor interaction underlying the activation of
PI3K-C2K, it seems likely that additional mechanisms must
be invoked to account for the relative speci¢city of IR com-
pared to IGFR in mediating activation of PI3K-C2K.
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Fig. 3. Lack of association between PI3K-C2K and the IR or
IGFR. Clonal lines of 3T3-L1 adipocytes were left unstimulated, or
stimulated with 4nM NT-3 for 0^30 min as indicated. Cells were
then lysed, immunoprecipitated (IP) with IR-, IGFR- or PI3K-C2K-
speci¢c antibody, resolved by SDS-PAGE, blotted onto PVDF
membranes and the blots probed with phosphotyrosine (PY) or
PI3K-C2K-speci¢c antibody. The regions of the blots containing the
chimaeric receptors (approx 160 kDa) (A) or PI3K-C2K (approx.
180 kDa) (B) are shown.
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